Can a simple conversation prevent deadly blood clots?

NCT ID NCT06731244

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a shared decision-making process, which uses personalized risk scores, can help patients with unprovoked blood clots choose the best duration of blood-thinning medication. The goal is to reduce the chance of another clot or serious bleeding while improving patient satisfaction. About 2,400 adults who have had a first unprovoked clot will be randomly assigned to usual care or the shared decision-making approach.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
shared decision-making process
What this could lead to
If successful, this approach could help patients and doctors choose the right duration of blood-thinning therapy, reducing the risk of another clot or serious bleeding.
What could go wrong
This is a large but early-stage study testing a decision-making process, not a drug. The results may not change current practice if the intervention does not clearly improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • APHM - Hôpital la Timone

    NOT_YET_RECRUITING

    Marseille, 13005, France

  • APHP-Colombes

    NOT_YET_RECRUITING

    Colombes, 92700, France

  • Aphp-Hegp

    NOT_YET_RECRUITING

    Paris, 75015, France

  • Aphp-Hegp

    NOT_YET_RECRUITING

    Paris, 75015, France

  • CH Le Mans

    NOT_YET_RECRUITING

    Le Mans, 72037, France

  • CHU Brest

    RECRUITING

    Brest, France, 29609, France

  • CHU Saint Etienne

    NOT_YET_RECRUITING

    Saint-Etienne, 42270 Saint Priest En Jarez, France

  • CHU d'Amiens - Picardie

    NOT_YET_RECRUITING

    Amiens, 80054, France

  • CHU d'Angers

    NOT_YET_RECRUITING

    Angers, 49933, France

  • CHU de Clermont Ferrand

    NOT_YET_RECRUITING

    Clermont-Ferrand, 63000, France

  • CHU de Dijon - Hôpital François Mitterand

    NOT_YET_RECRUITING

    Dijon, 21079, France

  • CHU de Montpellier

    NOT_YET_RECRUITING

    Montpellier, 34295, France

  • CHU de Nancy

    NOT_YET_RECRUITING

    Nancy, 54511, France

  • CHU de Nantes

    NOT_YET_RECRUITING

    Nantes, 44093, France

  • CHU de Nîmes

    NOT_YET_RECRUITING

    Nîmes, 30029, France

  • CHU de Rennes

    NOT_YET_RECRUITING

    Rennes, 35200, France

  • CHU de Strasbourg

    NOT_YET_RECRUITING

    Strasbourg, 67091, France

  • CHU de Toulouse

    NOT_YET_RECRUITING

    Toulouse, 31000, France

  • HCL - Hôpital Edouard Herriot

    NOT_YET_RECRUITING

    Lyon, 69003, France

  • Hôpital National d'Instruction des Armées Percy

    NOT_YET_RECRUITING

    Clamart, 92140, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.